• KSEBM
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Page Path

  • HOME
  • About
  • Best practice

Best practice

PRINCIPLES OF TRANSPARENCY AND BEST PRACTICE IN SCHOLARLY PUBLISHING

The Journal of Evidence-Based Practice (JEPB) adheres to Principles of Transparency and Best Practice in Scholarly Publishing (ver. 4, published September 15, 2022; https://doaj.org/apply/transparency) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME). Compliance checklist of the journal to the joint statement is as follows.

JOURNAL CONTENT JOURNAL PRACTICES ORGANISATION BUSINESS PRACTICES

JOURNAL CONTENT

1. Name of journal

The official journal title is Journal of Evidence-Based Practice (abbreviated as J Evid-Based Pract or JEBP).

2. WEBSITE

The official website of our journal is https://e-jebp.org. The JEBP team endeavors to make a high-quality website with accurate information and adherence to ethical and professional standards. It does not contain any misleading information, including any attempts to mimic other journal/publisher websites. Information for authors and readers is described in detail on the journal website. Key information can be found by clicking on the headings below.

3. JOURNAL SCHEDULE

JEBP is published two times a year on the last day of March and September.

4. ARCHIVING

JEBP provides electronic backup and digital preservation of the journal content in the event the journal is no longer published by archiving in National Library of Korea (https://www.nl.go.kr).

5. COPYRIGHT

As the official journal of the Korean Society of Evidence-Based Medicine, all published materials in JEBP are owned by the Korean Society of Evidence-Based Medicine. All authors must sign the copyright transfer agreement form upon submission. Copyright information is indicated on all published papers (HTML and PDF) and on the JEBP website.

6. LICENSING

JEBP is an open-access journal distributed under the terms of the Creative Commons License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original work is properly cited. The licensing information is indicated on all published papers (HTML and PDF) and on the JEBP website.

JOURNAL PRACTICES

7. PUBLICATION ETHICS AND RELATED EDITORIAL POLICIES

JEBP adheres to the guidance of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations).

The Editorial Board of JEBP carefully examines whether all submitted manuscripts abide the ethical guidelines of ICMJE and COPE. Published articles should include statements of conflict of interest, authors’ contribution, ethics committee or Institutional Review Board approval, informed consent, and human/animal rights. In case the journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by COPE (https://publicationethics.org). The discussion and decision on the suspected cases are carried out by the Editorial Board. JEBP will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

8. PEER REVIEW

The J Evid-Based Pract received the papers via ksebm.office@gmail.com.
All papers, including those invited by the editor, are subject to peer review. JEBP uses a double-blind peer review process, which means that author identities are concealed to the reviewers, and vice versa, and the identities of the reviewers and authors are visible to decision-making editor throughout the review process. The editor selects reviewers based on expertise, publication history, and past reviews. During the peer review process, reviewers can interact directly or exchange information (e.g., via submission systems or email) with only an editor, which is known as “independent review.” An initial decision will normally be made within 3 weeks after the reviewers agree to review a manuscript. No information about the review process or editorial decision process is published on the article page.
All manuscripts from editors, employees, or members of the Editorial Board are processed in the same way as other unsolicited manuscripts. However, those authors will not engage in the selection of reviewers and the decision process. Editors will not handle their manuscripts even if the manuscripts are commissioned. All articles in JEBP include the dates of submission, revision, acceptance, and publication on their article page.

9. ACCESS

JEBP is freely accessible from the journal website (https://e-jebp.org) according to the Creative Commons License (https://creativecommons.org/licenses/by-nc/4.0). Free full-text service both in the XML and PDF formats is available immediately upon publication without an embargo period.

ORGANISATION

10. OWNERSHIP AND MANAGEMENT

The journal is owned by the publisher, Korean Society of Evidence-Based Medicine. The full names and affiliations of the journal management team are available on the “Management team” page of the journal website: https://e-jebp.org/about/about/credential.php.

11. ADVISORY BODY

The Editorial Board serves as the journal's advisory body. The full names and affiliations of the members are provided on the Editorial Board page (https://e-jebp.org/about/editorial.php) of the website.

12. EDITORIAL TEAM AND CONTACT INFORMATION

BUSINESS PRACTICES

13. AUTHOR FEES

JEBP is a platinum open access journal that does not charge author fees. Thus, there are no fees for author submissions or other publication-related charges. The publisher fully covers all costs associated with the publication process.

14. OTHER REVENUE

The journal's revenue is primarily supported by the publisher, The Korean Society of Evidence-Based Medicine.

15. ADVERTISING

The journal does not accept any commercial product advertisements until policy changes otherwise.

16. DIRECT MARKETING

Journal propagation is achieved through the journal website and the distribution of an introductory pamphlet. Invitations to submit manuscripts are typically extended to presenters at conferences, seminars, or workshops that align with the journal's aims and scope.

JEBP recognizes the responsibility of publishers and editors to promote accessibility, diversity, equity, and inclusivity in all aspects of publication, as outlined in these principles. Editorial decisions are based solely on the scholarly merit of the manuscript and are not influenced by the author's nationality, ethnicity, political beliefs, race, or religion. JEBP is committed to promoting inclusiveness and regularly reviewing its policies to ensure they do not create barriers to participation.

TOP